These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 2150771)
1. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771 [TBL] [Abstract][Full Text] [Related]
2. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400 [TBL] [Abstract][Full Text] [Related]
3. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease. Yates CM; Simpson J; Gordon A Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479 [TBL] [Abstract][Full Text] [Related]
4. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117 [TBL] [Abstract][Full Text] [Related]
5. Evidence for a membrane defect in Alzheimer disease brain. Nitsch RM; Blusztajn JK; Pittas AG; Slack BE; Growdon JH; Wurtman RJ Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1671-5. PubMed ID: 1311847 [TBL] [Abstract][Full Text] [Related]
6. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390 [TBL] [Abstract][Full Text] [Related]
7. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Nitsch R; Pittas A; Blusztajn JK; Slack BE; Growdon JH; Wurtman RJ Ann N Y Acad Sci; 1991; 640():110-3. PubMed ID: 1663712 [TBL] [Abstract][Full Text] [Related]
8. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease. Mann DM; Yates PO; Marcyniuk B; Ravindra CR J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368 [TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor metabolic dysfunction in Down's syndrome brains. Iulita MF; Do Carmo S; Ower AK; Fortress AM; Flores Aguilar L; Hanna M; Wisniewski T; Granholm AC; Buhusi M; Busciglio J; Cuello AC Brain; 2014 Mar; 137(Pt 3):860-72. PubMed ID: 24519975 [TBL] [Abstract][Full Text] [Related]
10. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374 [TBL] [Abstract][Full Text] [Related]
11. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835 [TBL] [Abstract][Full Text] [Related]
12. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286 [TBL] [Abstract][Full Text] [Related]
13. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease. de la Monte SM; Hedley-Whyte ET J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772 [TBL] [Abstract][Full Text] [Related]
14. Abnormalities of the nucleus basalis in Down's syndrome. Casanova MF; Walker LC; Whitehouse PJ; Price DL Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050 [TBL] [Abstract][Full Text] [Related]
15. Dolichols are elevated in brain tissue from Alzheimer's disease, but not in urinary sediment from Alzheimer's disease and Down's syndrome. Wolfe LS; Ng Ying Kin NM; Palo J; Bergeron C; Kotila M; Varonen S Neurochem Pathol; 1985; 3(4):213-21. PubMed ID: 2938031 [TBL] [Abstract][Full Text] [Related]
16. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis. Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease in Down's syndrome. A review. Karlinsky H J Am Geriatr Soc; 1986 Oct; 34(10):728-34. PubMed ID: 2944942 [TBL] [Abstract][Full Text] [Related]
18. Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls. Metcalfe T; Bowen DM; Muller DP Neurochem Res; 1989 Dec; 14(12):1209-12. PubMed ID: 2534160 [TBL] [Abstract][Full Text] [Related]
19. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients. Singh VK; Fudenberg HH; Brown FR Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Glenner GG; Wong CW Biochem Biophys Res Commun; 1984 Aug; 122(3):1131-5. PubMed ID: 6236805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]